No light escapes from the collapsed Big Cancer star
As all you astrophysicists know, a black hole is a collapsed star that emits no light. It can be hard to get your head around such an extraordinary concept of space and time, so here’s a real-life example to help you: It’s like the cancer industry.
The gravitational forces of conventional medicine combine to ensure that no light escapes Big Cancer: no hope, no alternatives, no new ways to treat. These forces include doctors, their regulators, the drug industry and, in the UK, the Cancer Act, which blocks anyone from marketing any cancer therapy. Those who breach its strict code get a criminal record and could end up behind bars.
A team at University of Iowa Health Care has been battling these forces for 20 years. They’ve been exploring high-dose vitamin C as an effective cancer therapy which also, by the way, doesn’t have the life-destroying effects of chemotherapy.
Other researchers also looked at the vitamin and declared it didn’t work, but the Iowa team was one of the first to discover that it had to be given intravenously (IV) and not orally. With the IV route, high levels of the vitamin reach the blood, and this causes chemical reactions in cancer cells that make them more vulnerable to chemo.
The Iowa team has been pulling its punches, but advisedly so. It’s been getting its funding from the National Cancer Institute, which won’t support any research that eschews chemotherapy entirely, but WDDTY has gathered plenty of evidence down the years that shows the vitamin itself is doing the heavy lifting.
The Iowans have brought out a new study in recent months that shows the vitamin doubles the life expectancy of people with late-stage pancreatic cancer that’s spread.1
Usually the patient has a life expectancy of just eight months, but this doubles if high-dose vitamin C is given alongside chemotherapy. The researchers tested it on 34 patients with stage 4 metastatic pancreatic cancer, giving them either standard chemotherapy or chemotherapy and high-dose IV vitamin C.
The trial was such a success that the researchers ended it early and put everyone on the vitamin C drip.
“When we started the trial, we thought it would be a success if we got to 12 months’ survival, but we doubled overall survival to 16 months. The results were so strong in showing the benefit of this therapy for patient survival that we were able to stop the trial early,” said Dr Joe Cullen, one of the researchers.
Dr Cullen admits it’s been a bumpy road for his research team, who have met with continual scorn and skepticism from oncologists and the medical establishment. The bodies that regulate doctors make sure only the brave waver from the one true path of chemotherapy and radiation.
One who did was Dr Patrick Kingsley, a UK doctor who operated from his clinic in a tiny village in Leicestershire. Despite the clinic’s inaccessibility, thousands of people with late-stage cancers traveled from all over the world to find it and be treated by Dr Kingsley, whose main therapy was—yes, you guessed it—high-dose vitamin C, given intravenously. Doses varied but were usually around 10 g each time.
Dr Kingsley knew he was a last resort for many of his patients, but he lost surprisingly few. He kept doing his work under the radar, and you’d have to know someone who knew someone else who knew the person who had eaten at his local pub to know what he was up to.
Despite his success, the boot boys from the General Medical Council, the regulatory body for UK doctors, wanted to shut him down. They gave him two options: Pack up treating cancer patients or lose your license to practice as a doctor.
Not surprisingly, the goon squad didn’t say, “Wow, it’s amazing you’ve lost so few end-stage cancer patients. Do tell us what you’re doing; our bosses would love to roll this out to all doctors.”
Dr Kingsley took the road more often traveled, closed his clinic and stopped seeing cancer patients. Such are the gravitational forces of Big Cancer.
